Table 1.
Immunocompromised status (including potential immune dysregulation from the presence of ECLS itself) |
Prolonged duration of ECLSa |
Older agea |
Higher pre-ECLS severity of illnessa |
Underlying autoimmune disorder |
Central cannulation (vs peripheral cannulation) |
Surgical cannulation approach (vs percutaneous approach) |
ECLS extracorporeal life support
aThere are no specific cutoffs, per se, but the longer the duration of ECLS, the older the age, and the higher the pre-ECLS severity of illness, the higher the presumed risk